The TB Alliance is a nonprofit organization developing new treatments for tuberculosis (TB). It has built the largest portfolio of TB drug candidates in history, with three in late-stage clinical trials. Current TB treatments are long and ineffective against drug-resistant strains. The TB Alliance aims to develop shorter, simpler, and more effective TB therapies to address this urgent global health need. However, increased funding is needed to advance its pipeline of potential new TB drugs and treatments.